Endothelial p110γPI3K mediates endothelial regeneration and vascular repair after inflammatory vascular injury

Circulation

Volumn 133, Issue 11, 2016, Pages 1093-1103

  Huang, Xiaojia ^a   Dai, Zhiyu ^a   Cai, Lei ^a   Sun, Kai ^a   Cho, Jaehyung ^a   Albertine, Kurt H ^b   Malik, Asrar B ^a   Schraufnagel, Dean E ^a   Zhao, You Yang ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Endothelial regeneration; Endothelium, vascular; Inflammation; Vascular diseases; Vascular repair

Indexed keywords

LIPOPOLYSACCHARIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P110; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FORKHEAD BOX M1; UNCLASSIFIED DRUG; 2 (4 HYDROXYPHENYL) 4 MORPHOLINOPYRIDO[3',2':4,5]FURO[3,2 D]PYRIMIDINE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; 5-QUINOXALIN-6-YLMETHYLENETHIAZOLIDINE-2,4-DIONE; ANDROSTANE DERIVATIVE; FORKHEAD BOX PROTEIN M1; FORKHEAD TRANSCRIPTION FACTOR; FOXM1 PROTEIN, MOUSE; FURAN DERIVATIVE; HYBRID PROTEIN; ISOPROTEIN; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE; PIK3CG PROTEIN, HUMAN; PIK3CG PROTEIN, MOUSE; PYRIDINE DERIVATIVE; PYRIMIDINE DERIVATIVE; QUINOXALINE DERIVATIVE; WORTMANNIN;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL INJURY; BLOOD VESSEL PERMEABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; EDEMA; ENDOTHELIUM; ENDOTHELIUM CELL; HUMAN; HUMAN TISSUE; INFLAMMATION; LUNG BLOOD VESSEL; MICROVASCULATURE; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGENERATION; SEPSIS; SIGNAL TRANSDUCTION; VASCULAR SURGERY; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CAPILLARY LEAK SYNDROME; CAPILLARY PERMEABILITY; CELL CULTURE; DEFICIENCY; DRUG EFFECTS; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYMOLOGY; GENETIC TRANSFECTION; GENETICS; INJURIES; KNOCKOUT MOUSE; LUNG; LUNG EDEMA; METABOLISM; NEUTROPHIL; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ANDROSTADIENES; ANIMALS; CAPILLARY LEAK SYNDROME; CAPILLARY PERMEABILITY; CELLS, CULTURED; CLASS IB PHOSPHATIDYLINOSITOL 3-KINASE; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; ENZYME INDUCTION; FORKHEAD BOX PROTEIN M1; FORKHEAD TRANSCRIPTION FACTORS; FURANS; HUMANS; LUNG; MICE; MICE, KNOCKOUT; MICROVESSELS; NEUTROPHILS; PROTEIN ISOFORMS; PULMONARY EDEMA; PYRIDINES; PYRIMIDINES; QUINOXALINES; RECOMBINANT FUSION PROTEINS; REGENERATION; RESPIRATORY DISTRESS SYNDROME, ADULT; SEPSIS; SIGNAL TRANSDUCTION; THIAZOLIDINEDIONES; TRANSFECTION;

EID: 84957539873     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.115.020918     Document Type: Article

References (50)

1. Aird WC. Endothelium in health and disease. Pharmacol Rep. 2008;60:139-143.
2. Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, Pober JS, Wick TM, Konkle BA, Schwartz BS, Barnathan ES, McCrae KR, Hug BA, Schmidt AM, Stern DM. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood. 1998;91:3527-3561.
3. Mehta D, Malik AB. Signaling mechanisms regulating endothelial permeability. Physiol Rev. 2006;86:279-367. doi: 10.1152/physrev. 00012.2005.
4. Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev. 2004;84:767-801. doi: 10.1152/physrev.00041.2003.
5. Austin GE, Ratliff NB, Hollman J, Tabei S, Phillips DF. Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol. 1985;6:369-375.
6. Schwartz RS, Holmes DR Jr, Topol EJ. The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. J Am Coll Cardiol. 1992;20:1284-1293.
7. Mc Fadden EP, Bauters C, Lablanche JM, Quandalle P, Leroy F, Bertrand ME. Response of human coronary arteries to serotonin after injury by coronary angioplasty. Circulation. 1993;88(pt 1):2076-2085.
8. Ross R. Atherosclerosis: an infammatory disease. N Engl J Med. 1999;340:115-126. doi: 10.1056/NEJM199901143400207.
9. Libby P, Ridker PM, Maseri A. Infammation and atherosclerosis. Circulation. 2002;105:1135-1143.
10. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000;342:1334-1349. doi: 10.1056/NEJM200005043421806.
11. Zhao YY, Gao XP, Zhao YD, Mirza MK, Frey RS, Kalinichenko VV, Wang IC, Costa RH, Malik AB. Endothelial cell-restricted disruption of FoxM1 impairs endothelial repair following LPS-induced vascular injury. J Clin Invest. 2006;116:2333-2343. doi: 10.1172/JCI27154.
12. Minamino T, Komuro I. Regeneration of the endothelium as a novel therapeutic strategy for acute lung injury. J Clin Invest. 2006;116:2316-2319. doi: 10.1172/JCI29637.
13. London NR, Zhu W, Bozza FA, Smith MC, Greif DM, Sorensen LK, Chen L, Kaminoh Y, Chan AC, Passi SF, Day CW, Barnard DL, Zimmerman GA, Krasnow MA, Li DY. Targeting Robo4-dependent Slit signaling to survive the cytokine storm in sepsis and infuenza. Sci Transl Med. 2010;2:23ra19. doi: 10.1126/scitranslmed.3000678.
14. Lee WL, Slutsky AS. Sepsis and endothelial permeability. N Engl J Med. 2010;363:689-691. doi: 10.1056/NEJMcibr1007320.
15. Mirza MK, Sun Y, Zhao YD, Potula HH, Frey RS, Vogel SM, Malik AB, Zhao YY. FoxM1 regulates re-annealing of endothelial adherens junctions through transcriptional control of beta-catenin expression. J Exp Med. 2010;207:1675-1685. doi: 10.1084/jem.20091857.
16. Dejana E. Endothelial cell-cell junctions: happy together. Nat Rev Mol Cell Biol. 2004;5:261-270. doi: 10.1038/nrm1357.
17. Goldenberg NM, Steinberg BE, Slutsky AS, Lee WL. Broken barriers: a new take on sepsis pathogenesis. Sci Transl Med. 2011;3:88ps25. doi: 10.1126/scitranslmed.3002011.
18. Kaestner KH, Knochel W, Martinez DE. Unifed nomenclature for the winged helix/forkhead transcription factors. Genes Dev. 2000;14:142-146.
19. Costa RH. FoxM1 dances with mitosis. Nat Cell Biol. 2005;7:108-110. doi: 10.1038/ncb0205-108.
20. Kalinichenko VV, Gusarova GA, Tan Y, Wang IC, Major ML, Wang X, Yoder HM, Costa RH, Costal RH. Ubiquitous expression of the forkhead box M1B transgene accelerates proliferation of distinct pulmonary cell types following lung injury. J Biol Chem. 2003;278:37888-37894. doi: 10.1074/jbc.M305555200.
21. Laoukili J, Kooistra MR, Brás A, Kauw J, Kerkhoven RM, Morrison A, Clevers H, Medema RH. FoxM1 is required for execution of the mitotic programme and chromosome stability. Nat Cell Biol. 2005;7:126-136. doi: 10.1038/ncb1217.
22. Ye H, Kelly TF, Samadani U, Lim L, Rubio S, Overdier DG, Roebuck KA, Costa RH. Hepatocyte nuclear factor 3/fork head homolog 11 is expressed in proliferating epithelial and mesenchymal cells of embryonic and adult tissues. Mol Cell Biol. 1997;17:1626-1641.
23. Whitman M, Kaplan DR, Schaffhausen B, Cantley L, Roberts TM. Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation. Nature. 1985;315:239-242.
24. Leevers SJ, Vanhaesebroeck B, Waterfeld MD. Signalling through phos-phoinositide 3-kinases: the lipids take centre stage. Curr Opin Cell Biol. 1999;11:219-225.
25. Stephens LR, Eguinoa A, Erdjument-Bromage H, Lui M, Cooke F, Coadwell J, Smrcka AS, Thelen M, Cadwallader K, Tempst P, Hawkins PT. The G beta gamma sensitivity of a PI3K is dependent upon a tightly associated adaptor, p101. Cell. 1997;89:105-114.
26. Guillermet-Guibert J, Bjorklof K, Salpekar A, Gonella C, Ramadani F, Bilancio A, Meek S, Smith AJ, Okkenhaug K, Vanhaesebroeck B. The p110beta isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110gamma. Proc Natl Acad Sci USA. 2008;105:8292-8297. doi: 10.1073/pnas.0707761105.
27. Hirsch E, Katanaev VL, Garlanda C, Azzolino O, Pirola L, Silengo L, Sozzani S, Mantovani A, Altruda F, Wymann MP. Central role for G protein-coupled phosphoinositide 3-kinase gamma in infammation. Science. 2000;287:1049-1053.
28. Ferguson GJ, Milne L, Kulkarni S, Sasaki T, Walker S, Andrews S, Crabbe T, Finan P, Jones G, Jackson S, Camps M, Rommel C, Wymann M, Hirsch E, Hawkins P, Stephens L. PI(3)Kgamma has an important context-dependent role in neutrophil chemokinesis. Nat Cell Biol. 2007;9:86-91. doi: 10.1038/ncb1517.
29. Ong E, Gao XP, Predescu D, Broman M, Malik AB. Role of phos-phatidylinositol 3-kinase-gamma in mediating lung neutrophil sequestration and vascular injury induced by E. coli sepsis. Am J Physiol Lung Cell Mol Physiol. 2005;289:L1094-L1103. doi: 10.1152/ajplung.00179.2005.
30. Yum HK, Arcaroli J, Kupfner J, Shenkar R, Penninger JM, Sasaki T, Yang KY, Park JS, Abraham E. Involvement of phosphoinositide 3-kinases in neutrophil activation and the development of acute lung injury. J Immunol. 2001;167:6601-6608.
31. Sasaki T, Irie-Sasaki J, Jones RG, Oliveira-dos-Santos AJ, Stanford WL, Bolon B, Wakeham A, Itie A, Bouchard D, Kozieradzki I, Joza N, Mak TW, Ohashi PS, Suzuki A, Penninger JM. Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration. Science. 2000;287:1040-1046.
32. Hers I. Insulin-like growth factor-1 potentiates platelet activation via the IRS/PI3Kalpha pathway. Blood. 2007;110:4243-4252. doi: 10.1182/blood-2006-10-050633.
33. Camps M, Rückle T, Ji H, Ardissone V, Rintelen F, Shaw J, Ferrandi C, Chabert C, Gillieron C, Françon B, Martin T, Gretener D, Perrin D, Leroy D, Vitte PA, Hirsch E, Wymann MP, Cirillo R, Schwarz MK, Rommel C. Blockade of PI3Kgamma suppresses joint infammation and damage in mouse models of rheumatoid arthritis. Nat Med. 2005;11:936-943. doi: 10.1038/nm1284.
34. Huang X, Zhao YY Transgenic expression of FoxM1 promotes endothelial repair following lung injury induced by polymicrobial sepsis in mice. PLoS One. 2012;7:e50094. doi: 10.1371/journal.pone.0050094.
35. Prandini MH, Dreher I, Bouillot S, Benkerri S, Moll T, Huber P. The human VE-cadherin promoter is subjected to organ-specifc regulation and is activated in tumour angiogenesis. Oncogene. 2005;24:2992-3001. doi: 10.1038/sj.onc.1208483.
36. Albertine KH, Soulier MF, Wang Z, Ishizaka A, Hashimoto S, Zimmerman GA, Matthay MA, Ware LB. Fas and fas ligand are up-regulated in pulmonary edema fuid and lung tissue of patients with acute lung injury and the acute respiratory distress syndrome. Am J Pathol. 2002;161:1783-1796. doi: 10.1016/S0002-9440(10)64455-0.
37. Nagashima T, Shigematsu N, Maruki R, Urano Y, Tanaka H, Shimaya A, Shimokawa T, Shibasaki M. Discovery of novel forkhead box O1 inhibitors for treating type 2 diabetes: improvement of fasting glycemia in diabetic db/db mice. Mol Pharmacol. 2010;78:961-970. doi: 10.1124/mol.110.065714.
38. Schroeder FC, Kau TR, Silver PA, Clardy J. The psammaplysenes, specifc inhibitors of FOXO1a nuclear export. J Nat Prod. 2005;68:574-576. doi: 10.1021/np049624z.
39. Wang H, Teh MT, Ji Y, Patel V, Firouzabadian S, Patel AA, Gutkind JS, Yeudall WA. EPS8 upregulates FOXM1 expression, enhancing cell growth and motility. Carcinogenesis. 2010;31:1132-1141. doi: 10.1093/carcin/bgq058.
40. Tibolla G, Piñeiro R, Chiozzotto D, Mavrommati I, Wheeler AP, Norata GD, Catapano AL, Maffucci T, Falasca M. Class II phosphoinositide 3-kinases contribute to endothelial cells morphogenesis. PLoS One. 2013;8:e53808. doi: 10.1371/journal.pone.0053808.
41. Kok K, Geering B, Vanhaesebroeck B. Regulation of phosphoinositide 3-kinase expression in health and disease. Trends Biochem Sci. 2009;34:115-127. doi: 10.1016/j.tibs.2009.01.003.
42. Rückle T, Schwarz MK, Rommel C. PI3Kgamma inhibition: towards an "aspirin of the 21st century"? Nat Rev Drug Discov. 2006;5:903-918. doi: 10.1038/nrd2145.
43. Vanhaesebroeck B, Guillermet-Guibert J, Graupera M, Bilanges B. The emerging mechanisms of isoform-specifc PI3K signalling. Nat Rev Mol Cell Biol. 2010;11:329-341. doi: 10.1038/nrm2882.
44. Cepinskas G, Noseworthy R, Kvietys PR. Transendothelial neutrophil migration: role of neutrophil-derived proteases and relationship to transendothelial protein movement. Circ Res. 1997;81:618-626.
45. Fernandez-Borja M, van Buul JD, Hordijk PL. The regulation of leucocyte transendothelial migration by endothelial signalling events. Cardiovasc Res. 2010;86:202-210. doi: 10.1093/cvr/cvq003.
46. Kim DI, Kim SR, Kim HJ, Lee SJ, Lee HB, Park SJ, Im MJ, Lee YC. PI3K-y inhibition ameliorates acute lung injury through regulation of IKBa/NF-KB pathway and innate immune responses. J Clin Immunol. 2012;32:340-351. doi: 10.1007/s10875-011-9628-1.
47. Williams DL, Li C, Ha T, Ozment-Skelton T, Kalbfeisch JH, Preiszner J, Brooks L, Breuel K, Schweitzer JB. Modulation of the phosphoinositide 3-kinase pathway alters innate resistance to polymicrobial sepsis. J Immunol. 2004;172:449-456.
48. Wrann CD, Tabriz NA, Barkhausen T, Klos A, van Griensven M, Pape HC, Kendoff DO, Guo R, Ward PA, Krettek C, Riedemann NC. The phosphatidylinositol 3-kinase signaling pathway exerts protective effects during sepsis by controlling C5a-mediated activation of innate immune functions. J Immunol. 2007;178:5940-5948.
49. Maus UA, Backi M, Winter C, Srivastava M, Schwarz MK, Rückle T, Paton JC, Briles D, Mack M, Welte T, Maus R, Bohle RM, Seeger W, Rommel C, Hirsch E, Lohmeyer J, Preissner KT. Importance of phosphoinositide 3-kinase gamma in the host defense against pneumococcal infection. Am J Respir Crit Care Med. 2007;175:958-966. doi: 10.1164/rccm.200610-1533OC.
50. Martin EL, Souza DG, Fagundes CT, Amaral FA, Assenzio B, Puntorieri V, Del Sorbo L, Fanelli V, Bosco M, Delsedime L, Pinho JF, Lemos VS, Souto FO, Alves-Filho JC, Cunha FQ, Slutsky AS, Ruckle T, Hirsch E, Teixeira MM, Ranieri VM. Phosphoinositide-3 kinase gamma activity contributes to sepsis and organ damage by altering neutrophil recruitment. Am J Respir Crit Care Med. 2010;182:762-773. doi: 10.1164/rccm.201001-0088OC.